Uniphar
Uniphar PLC is an Irish international healthcare services company engaged in pharmaceutical wholesaling, specialty distribution, and commercial execution services for biopharmaceutical manufacturers. The company operates through three core business divisions: Commercial & Clinical, providing outsourcing and market access solutions; Product Access, distributing unlicensed and specialty medicines globally; and Supply Chain & Retail, operating community pharmacies and pharmaceutical wholesale logistics across Ireland. Principal revenue is derived from wholesale pharmaceutical distribution margins, specialty logistics fees, commercial execution contracts, and retail pharmacy sales. Uniphar holds a dominant market position in Irish pharmaceutical distribution alongside expanding international specialty healthcare operations. Headquartered in Dublin, Ireland, the company's common stock is dual-listed and traded on Euronext Dublin and the AIM market of the London Stock Exchange under the ticker UPR.
14 of the funds FundTelligence covers report a position in Uniphar.
- Legal name
- Uniphar Plc
- Sector
- Health Care
- Country
- Ireland
- Funds holding it
- 14
Funds holding Uniphar
- Danske Invest Europe Small Cap — Danske Invest · 3.2 % (largest positions only, October 2026)
- Polar Capital Healthcare Opportunities Fund — Polar Capital · 3.0 % (largest positions only, October 2026)
- Swedbank Robur Small Cap Global — Swedbank · 2.76 % (full portfolio disclosed, October 2026)
- Lannebo Europa Småbolag — Lannebo · 2.21 % (full portfolio disclosed, June 2026)
- Cliens Global Småbolag — Cliens · 1.62 % (full portfolio disclosed, June 2026)
- Handelsbanken Europa SMB — Handelsbanken · 1.51 % (full portfolio disclosed, October 2026)
- Lannebo Global Småbolag — Lannebo · 1.01 % (full portfolio disclosed, June 2026)
- JPM Europe Small Cap Fund — JPM · 0.93 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 14 funds holding it.